» Articles » PMID: 25466442

Screening for Latent TB, HIV, and Hepatitis B/C in New Migrants in a High Prevalence Area of London, UK: a Cross-sectional Study

Overview
Journal BMC Infect Dis
Publisher Biomed Central
Date 2014 Dec 4
PMID 25466442
Citations 17
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Rising rates of infectious diseases in international migrants has reignited the debate around screening. There have been calls to strengthen primary-care-based programmes, focusing on latent TB. We did a cross-sectional study of new migrants to test an innovative one-stop blood test approach to detect multiple infections at one appointment (HIV, latent tuberculosis, and hepatitis B/C) on registration with a General Practitioner (GP) in primary care.

Methods: The study was done across two GP practices attached to hospital Accident and Emergency Departments (A&E) in a high migrant area of London for 6 months. Inclusion criteria were foreign-born individuals from a high TB prevalence country (>40 cases per 100,000) who have lived in the UK ≤ 10 years, and were over 18 years of age. All new migrants who attended a New Patient Health Check were screened for eligibility and offered the blood test. We followed routine care pathways for follow-up.

Results: There were 1235 new registrations in 6 months. 453 attended their New Patient Health Check, of which 47 (10.4%) were identified as new migrants (age 32.11 years [range 18-72]; 22 different nationalities; time in UK 2.28 years [0-10]). 36 (76.6%) participated in the study. The intervention only increased the prevalence of diagnosed latent TB (18.18% [95% CI 6.98-35.46]; 181.8 cases per 1000). Ultimately 0 (0%) of 6 patients with latent TB went on to complete treatment (3 did not attend referral). No cases of HIV or hepatitis B/C were found. Foreign-born patients were under-represented at these practices in relation to 2011 Census data (Chi-square test -0.111 [95% CI -0.125 to -0.097]; p < 0.001).

Conclusion: The one-stop approach was feasible in this context and acceptability was high. However, the number of presenting migrants was surprisingly low, reflecting the barriers to care that this group face on arrival, and none ultimately received treatment. The ongoing UK debate around immigration checks and charging in primary care for new migrants can only have negative implications for the promotion of screening in this group. Until GP registration is more actively promoted in new migrants, a better place to test this one-stop approach could be in A&E departments where migrants may present in larger numbers.

Citing Articles

Health Catch-UP!: a realist evaluation of an innovative multi-disease screening and vaccination tool in UK primary care for at-risk migrant patients.

Carter J, Goldsmith L, Knights F, Deal A, Jayakumar S, Crawshaw A BMC Med. 2024; 22(1):497.

PMID: 39468557 PMC: 11520889. DOI: 10.1186/s12916-024-03713-4.


Tuberculosis screening in the European migrant population: a scoping review of current practices.

Braga S, Vieira M, Barbosa P, Ramos J, Duarte R Breathe (Sheff). 2024; 20(1):230357.

PMID: 38746905 PMC: 11091716. DOI: 10.1183/20734735.0357-2023.


Multi-infection screening for migrant patients in UK primary care: Challenges and opportunities.

Carter J, Knights F, Deal A, Crawshaw A, Hayward S, Hall R J Migr Health. 2023; 9:100203.

PMID: 38059072 PMC: 10696453. DOI: 10.1016/j.jmh.2023.100203.


Screening for neglected tropical diseases and other infections in refugee and asylum-seeker populations in the United Kingdom.

Cinardo P, Farrant O, Gunn K, Ward A, Eisen S, Longley N Ther Adv Infect Dis. 2022; 9:20499361221116680.

PMID: 35958977 PMC: 9358592. DOI: 10.1177/20499361221116680.


Initiation and completion of treatment for latent tuberculosis infection in migrants globally: a systematic review and meta-analysis.

Rustage K, Lobe J, Hayward S, Kristensen K, Margineanu I, Stienstra Y Lancet Infect Dis. 2021; 21(12):1701-1712.

PMID: 34363771 PMC: 8612939. DOI: 10.1016/S1473-3099(21)00052-9.


References
1.
Hargreaves S, Carballo M, Friedland J . Screening migrants for tuberculosis: where next?. Lancet Infect Dis. 2009; 9(3):139-40. DOI: 10.1016/S1473-3099(09)70026-X. View

2.
Bothamley G, Rowan J, Griffiths C, Beeks M, McDonald M, Beasley E . Screening for tuberculosis: the port of arrival scheme compared with screening in general practice and the homeless. Thorax. 2002; 57(1):45-9. PMC: 1746167. DOI: 10.1136/thorax.57.1.45. View

3.
Hargreaves S, Friedland J, Gothard P, Saxena S, Millington H, Eliahoo J . Impact on and use of health services by international migrants: questionnaire survey of inner city London A&E attenders. BMC Health Serv Res. 2006; 6:153. PMC: 1698917. DOI: 10.1186/1472-6963-6-153. View

4.
Brewin P, Jones A, Kelly M, McDonald M, Beasley E, Sturdy P . Is screening for tuberculosis acceptable to immigrants? A qualitative study. J Public Health (Oxf). 2006; 28(3):253-60. DOI: 10.1093/pubmed/fdl031. View

5.
Veldhuijzen I, Toy M, Hahne S, de Wit G, Schalm S, de Man R . Screening and early treatment of migrants for chronic hepatitis B virus infection is cost-effective. Gastroenterology. 2009; 138(2):522-30. DOI: 10.1053/j.gastro.2009.10.039. View